$63.06M
Revenue
$-41.21M
Net Income
78.29%
Gross Margin
-72.78%
Op. Margin
$-52.59M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Total Revenue | $63.06M | $63.06M | $59.68M |
| Revenue Growth % | 0.0% | 5.7% | nan% |
| Cost of Revenue | $13.69M | $13.69M | $12.04M |
| Gross Profit | $49.37M | $49.37M | $47.64M |
| Gross Margin % | 78.3% | 78.3% | 79.8% |
| Operating Expenses | $95.27M | $95.27M | $87.92M |
| Research & Development | $29.86M | $29.86M | $20.74M |
| Operating Income | $-45.90M | $-45.90M | $-40.28M |
| Operating Margin % | -72.8% | -72.8% | -67.5% |
| Interest Expense | - | $359.00K | $498.00K |
| Interest Income | $1.95M | $1.95M | $2.98M |
| Other Income/Expense | - | $-697.00K | $-899.00K |
| Income Before Tax | $-44.65M | $-44.65M | $-38.92M |
| Income Tax Expense | $-3.44M | $-3.44M | $484.00K |
| Net Income | $-41.21M | $-41.21M | $-39.40M |
| Net Margin % | -65.3% | -65.3% | -66.0% |
| Basic EPS | nan | -1.39 | -1.53 |
| Diluted EPS | nan | -1.39 | -1.53 |
| Basic Shares Outstanding | 329K | 29.7M | 25.7M |
| Diluted Shares Outstanding | 329K | 29.7M | 25.7M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|
| Cash & Cash Equivalents | $9.01M | $19.61M |
| Accounts Receivable | $9.71M | $9.21M |
| Other Current Assets | $4.73M | $3.46M |
| Total Current Assets | $46.08M | $107.28M |
| Property Plant & Equipment | $1.52M | $865.00K |
| Goodwill | $30.07M | $9.03M |
| Intangible Assets | $26.03M | $4.37M |
| Other Non-current Assets | $1.56M | $1.70M |
| Total Assets | $122.64M | $142.34M |
| Accounts Payable | $3.48M | $3.32M |
| Accrued Liabilities | $19.40M | $19.80M |
| Deferred Revenue | $10.75M | $7.50M |
| Total Current Liabilities | $38.40M | $34.49M |
| Other Non-current Liabilities | $94.00K | $307.00K |
| Total Liabilities | $47.65M | $42.26M |
| Common Stock | $3.00K | $3.00K |
| Retained Earnings | $-69.22M | $-28.01M |
| Total Stockholders Equity | $74.99M | $100.08M |
| Total Liabilities & Equity | $122.64M | $142.34M |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Net Income | $-60.48M | $-41.21M | $-39.40M |
| Depreciation & Amortization | $5.05M | $3.47M | $1.28M |
| Stock-based Compensation | $17.49M | $10.81M | $26.91M |
| Change in Receivables | $-5.91M | $-2.29M | $5.97M |
| Change in Payables | $-3.54M | $-781.00K | $1.33M |
| Operating Cash Flow | $-51.65M | $-33.91M | $-19.77M |
| Capital Expenditure | $936.00K | $618.00K | $505.00K |
| Sales of Investments | $89.90M | $34.90M | $33.60M |
| Investing Cash Flow | $72.94M | $33.72M | $-66.53M |
| Financing Cash Flow | $-4.32M | $-2.21M | $101.30M |
| Net Change in Cash | $17.56M | $-2.35M | $15.19M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $18.67M | $10.97M | $44.81M | $41.82M |
| Cost of Revenue | $4.13M | $2.79M | $10.65M | $9.62M |
| Gross Profit | $14.54M | $8.19M | $34.16M | $32.20M |
| Operating Expenses | $23.88M | $15.49M | $73.28M | $74.90M |
| Research & Development | $8.74M | $4.13M | $19.45M | $15.46M |
| Operating Income | $-9.34M | $-7.30M | $-39.12M | $-42.70M |
| Interest Income | $316.00K | $1.22M | $1.83M | $1.90M |
| Other Income/Expense | $82.00K | $-278.00K | $-652.00K | $-832.00K |
| Income Before Tax | $-8.94M | $-6.36M | $-37.94M | $-42.35M |
| Income Tax Expense | $-3.65M | $188.00K | $-3.96M | $1.21M |
| Net Income | $-5.30M | $-6.55M | $-33.98M | $-43.56M |
| Basic EPS | -0.18 | -0.23 | -1.16 | -1.77 |
| Diluted EPS | -0.18 | -0.23 | -1.16 | -1.77 |
| Basic Shares Outstanding | $30.21M | $29.05M | $29.41M | $24.63M |
| Diluted Shares Outstanding | $30.21M | $29.05M | $29.41M | $24.63M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $11.95M | $19.61M |
| Accounts Receivable | $7.49M | $9.21M |
| Other Current Assets | $5.09M | $3.46M |
| Total Current Assets | $53.00M | $107.28M |
| Property Plant & Equipment | $1.69M | $865.00K |
| Goodwill | $30.56M | $9.03M |
| Intangible Assets | $27.14M | $4.37M |
| Other Non-current Assets | $1.55M | $1.70M |
| Total Assets | $130.59M | $142.34M |
| Accounts Payable | $3.64M | $3.32M |
| Accrued Liabilities | $23.13M | $19.80M |
| Deferred Revenue | $11.35M | $7.50M |
| Total Current Liabilities | $41.76M | $34.49M |
| Other Non-current Liabilities | $1.10M | $307.00K |
| Total Liabilities | $51.49M | $42.26M |
| Common Stock | $3.00K | $3.00K |
| Retained Earnings | $-61.99M | $-28.01M |
| Total Stockholders Equity | $79.10M | $100.08M |
| Total Liabilities & Equity | $130.59M | $142.34M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-5.30M | $-6.55M | $-33.98M | $-43.56M |
| Depreciation & Amortization | - | - | $2.24M | $903.00K |
| Stock-based Compensation | - | - | $7.47M | $24.39M |
| Change in Receivables | - | - | $-3.86M | $1.34M |
| Change in Payables | - | - | $-630.00K | $1.02M |
| Operating Cash Flow | - | - | $-24.43M | $-10.67M |
| Capital Expenditure | - | - | $580.00K | $344.00K |
| Sales of Investments | - | - | $34.90M | $9.00M |
| Investing Cash Flow | - | - | $31.19M | $-72.95M |
| Financing Cash Flow | - | - | $-2.24M | $105.55M |
| Net Change in Cash | - | - | $4.71M | $22.18M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.